Sm. Levitz et al., PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA IN HUMAN-LEUKOCYTES STIMULATED BY CRYPTOCOCCUS-NEOFORMANS, Infection and immunity, 62(5), 1994, pp. 1975-1981
Tumor necrosis factor alpha (TNF-alpha) is a key mediator of inflammat
ion and may promote human immunodeficiency virus replication in latent
ly infected cells. Since cryptococcosis often is associated with aberr
ations in the host inflammatory response and occurs preferentially in
persons with AIDS, we defined the conditions under which human leukocy
tes produce TNF-alpha when stimulated by Cryptococcus neoformans. Peri
pheral blood mononuclear cells (PBMC) produced comparable amounts of T
NF-alpha, following stimulation with C. neoformans and lipopolysacchar
ide. Detectable TNF-alpha release in response to C. neoformans occurre
d only when fungi,vith small-sized capsules were used and complement-s
ufficient serum was added. Fractionation of PBMC established that mono
cytes were the predominant source of TNF-alpha. TTF-alpha gene express
ion and release occurred significantly later in PBMC stimulated with C
. neoformans than in PBMC stimulated with LPS. C. neoformans was also
a potent inducer of TNF-alpha from freshly isolated bronchoalveolar ma
crophages (BAM). Upon in vitro culture, BAM and monocytes bound greate
r numbers of fungal cells, yet their capacity to produce TNF-alpha fol
lowing cryptococcal stimulation declined by 74 to 100%. However, this
decline was reversed if the BAM and monocytes were cultured with gamma
interferon. These data establish that C. neoformans can potently stim
ulate TNF-alpha release from human leukocytes. However, several variab
les profoundly affected the amount of TNF-alpha released, including th
e type of leukocyte and its state of activation, the size of the crypt
ococcal capsule, and the availability of opsonins.